BRIEF published on 12/05/2025 at 18:39, 3 months 20 days ago Valneva Updates Share and Voting Rights as of November 2025 Stock Options Euronext Paris Voting Rights Valneva Double Voting Rights
BRIEF published on 12/05/2025 at 18:39, 3 months 20 days ago VALNEVA: Declaration of Shares and Voting Rights Euronext Paris Voting Rights Ordinary Shares Valneva 2025
PRESS RELEASE published on 12/05/2025 at 18:34, 3 months 20 days ago VALNEVA Declaration of shares and voting rights: November 30, 2025 VALNEVA declares changes in shares and voting rights, including double voting rights granted on ordinary shares and transfer into bearer form Euronext Paris Voting Rights Shares Valneva Double Voting Rights
BRIEF published on 12/03/2025 at 11:03, 3 months 22 days ago Valneva SE: Promising Developments in Lyme Disease Vaccine Valneva SE Lyme Disease Vaccine Market Forecast Pfizer VLA15
PRESS RELEASE published on 12/03/2025 at 10:58, 3 months 22 days ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Buy recommendation for Valneva SE, raising target price to €6.80. VLA15 vaccine progress and market potential analyzed Buy Recommendation Research Update Valneva SE Market Potential VLA15 Vaccine
BRIEF published on 11/04/2025 at 07:05, 4 months 21 days ago Valneva's Phase 1 Trial Yields Positive Results for Zika Vaccine Phase 1 Trial Valneva Immunogenicity Zika Vaccine Adjuvant
PRESS RELEASE published on 11/04/2025 at 07:00, 4 months 21 days ago Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate Valneva SE reports positive Phase 1 trial results for VLA1601, its second-generation Zika vaccine candidate, showing improved immune response. Safety and immunogenicity demonstrated in trial Phase 1 Trial Valneva SE Safety Immunogenicity Zika Vaccine
BRIEF published on 10/09/2025 at 16:04, 5 months 16 days ago Bpifrance Crosses Threshold in the Capital of Valneva SE Stock Market Valneva SE Threshold Crossing Bpifrance Deposit Fund
BRIEF published on 10/06/2025 at 07:35, 5 months 19 days ago Valneva Updates on Shares and Voting Rights Voting Rights Shares Euronext Valneva France
PRESS RELEASE published on 10/06/2025 at 07:30, 5 months 19 days ago VALNEVA Declaration of shares and voting rights: September 30, 2025 Valneva declares transfer into bearer form of 653 shares with double voting rights and grants double voting rights on 100 ordinary shares, affecting total voting rights Voting Rights Valneva Shares Transfer Double Rights Bearer Form
Published on 03/26/2026 at 00:40, 3 hours 27 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 3 hours 37 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 8 hours 52 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 14 hours 37 minutes ago Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 14 hours 37 minutes ago Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/26/2026 at 01:05, 3 hours 2 minutes ago Blokees Announces Upgrade Brand Mission at 2026 Global Partner Conference
Published on 03/25/2026 at 20:00, 8 hours 7 minutes ago Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 19:41, 8 hours 26 minutes ago EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
Published on 03/25/2026 at 19:30, 8 hours 37 minutes ago AIXTRON to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 19:26, 8 hours 41 minutes ago EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 18:31, 9 hours 36 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 10 hours 22 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
